Spots Global Cancer Trial Database for ttfields
Every month we try and update this database with for ttfields cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | NCT03940196 | Ovarian Cancer | NovoTTF-100L(O) Paclitaxel | 18 Years - | NovoCure Ltd. | |
| Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) | NCT00916409 | Glioblastoma Mu... | NovoTTF-100A de... Temozolomide | 18 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | NCT02973789 | Nonsmall Cell L... NSCLC | NovoTTF-200T Immune checkpoi... | 22 Years - | NovoCure Ltd. | |
| Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma | NCT06222138 | Glioblastoma | The samples des... | 18 Years - | Institut Claudius Regaud | |
| EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer | NCT04892472 | Non-small Cell ... | NovoTTF-200T Pembrolizumab (... | 22 Years - | NovoCure Ltd. | |
| Post-approval Study of NovoTTF-100A in Recurrent GBM Patients | NCT01756729 | Recurrent Gliob... | NovoTTF-100A | 22 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | NCT03940196 | Ovarian Cancer | NovoTTF-100L(O) Paclitaxel | 18 Years - | NovoCure Ltd. | |
| Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | NCT02973789 | Nonsmall Cell L... NSCLC | NovoTTF-200T Immune checkpoi... | 22 Years - | NovoCure Ltd. | |
| TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study | NCT05538806 | Pleural Mesothe... | TTFields | 18 Years - | NovoCure Ltd. | |
| Post-approval Study of NovoTTF-100A in Recurrent GBM Patients | NCT01756729 | Recurrent Gliob... | NovoTTF-100A | 22 Years - | NovoCure Ltd. | |
| Enhancing Optune Therapy With Targeted Craniectomy | NCT02893137 | Glioblastoma | Optune Craniectomy | 18 Years - | University of Aarhus | |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) | NCT02397928 | Malignant Pleur... | NovoTTF-100L de... Pemetrexed Cisplatin or Ca... | 18 Years - | NovoCure Ltd. | |
| Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery) | NCT04223999 | Recurrent Gliob... | Skullremodeling... Control | 18 Years - | University of Aarhus | |
| Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma | NCT02743078 | Glioblastoma Glioma Gliosarcoma | Bevacizumab TTFields Therap... | 22 Years - | RTOG Foundation, Inc. | |
| Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
| A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC | NCT05698264 | Non Small Cell ... EGFR Gene Mutat... Immune Checkpoi... | concomitant TTF... concomitant TTF... | 18 Years - | Shaare Zedek Medical Center | |
| Post-approval Study of NovoTTF-100A in Recurrent GBM Patients | NCT01756729 | Recurrent Gliob... | NovoTTF-100A | 22 Years - | NovoCure Ltd. | |
| Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma | NCT06222138 | Glioblastoma | The samples des... | 18 Years - | Institut Claudius Regaud | |
| Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) | NCT03377491 | Pancreas Adenoc... | NovoTTF-200T Gemcitabine nab paclitaxel | 18 Years - | NovoCure Ltd. | |
| Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma | NCT06222138 | Glioblastoma | The samples des... | 18 Years - | Institut Claudius Regaud | |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) | NCT02397928 | Malignant Pleur... | NovoTTF-100L de... Pemetrexed Cisplatin or Ca... | 18 Years - | NovoCure Ltd. | |
| TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study | NCT04717739 | Glioblastoma | TTFields | 18 Years - | NovoCure Ltd. | |
| NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy | NCT03194971 | Glioblastoma | Tumor samples f... Tumor samples f... | 18 Years - | Medical College of Wisconsin | |
| A Prospective, Open-label, Single-arm Clinical Study | NCT04689087 | Recurrent Gliob... | TTFields | 18 Years - | Sun Yat-sen University | |
| TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study | NCT05538806 | Pleural Mesothe... | TTFields | 18 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma | NCT04281576 | Gastric Cancer GastroEsophagea... | NovoTTF-100L(P) Oxaliplatin Capecitabine Trastuzumab | 18 Years - | NovoCure Ltd. | |
| Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM) | NCT00379470 | Recurrent Gliob... | NovoTTF-100A | 18 Years - | NovoCure Ltd. | |
| TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | NCT03780569 | Glioblastoma Mu... | NovoTTF-200A Radiotherapy Temozolomide | 18 Years - | NovoCure Ltd. | |
| NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy | NCT03194971 | Glioblastoma | Tumor samples f... Tumor samples f... | 18 Years - | Medical College of Wisconsin | |
| Preoperative Preradiotherapy TTFields | NCT06136611 | Glioblastoma | TTFields | 35 Years - | The Christie NHS Foundation Trust | |
| TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study | NCT04717739 | Glioblastoma | TTFields | 18 Years - | NovoCure Ltd. | |
| TTFields In GErmany in Routine Clinical Care | NCT03258021 | Glioblastoma | TTFields | 18 Years - | NovoCure Ltd. | |
| A Prospective, Open-label, Single-arm Clinical Study | NCT04689087 | Recurrent Gliob... | TTFields | 18 Years - | Sun Yat-sen University | |
| TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine | NCT04671459 | Glioblastoma Mu... Recurrent Gliob... | TTFields and SR... | 18 Years - | Prof. Franciszek Lukaszczyk Memorial Oncology Center | |
| TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | NCT03780569 | Glioblastoma Mu... | NovoTTF-200A Radiotherapy Temozolomide | 18 Years - | NovoCure Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
